获得的血友病A伪装为抗凝血的出血:一个病例报告,包括关键的实验室考虑
Michael MacNeill1, Eman M Mansory2, Alejandro Lazo-Langner3
1Medicine, Schulich School of Medicine & Dentistry, Western University, London, CAN.
Cureus
|July 31, 2023
概括
一种罕见的自身免疫性出血障碍,获得的血友病A,在接受肺栓塞抗凝剂治疗的患者中引起了复发性血液瘤. 由于并发性血栓和出血导致诊断延迟,导致长时间住院治疗.
科学领域:
- 血液学 血液学 血液学
- 自身免疫性疾病 自身免疫性疾病
- 凝血障碍 凝血障碍 凝血障碍
背景情况:
- 获得性血友病A (AHA) 是一种罕见的自身免疫性出血疾病,由对凝血因子VIII (FVIII) 的自身抗体引起.
- AHA提出了诊断挑战,特别是在需要抗凝药的并发血栓症患者中.
研究的目的:
- 在接受抗凝药治疗的肺栓塞患者中报告AHA病例.
- 突出诊断延迟和管理复杂性在这种情况下.
- 强调需要提高意识和改进实验室解释的必要性.
主要方法:
- 一个患有复发性血液瘤和肺栓塞的病人的病例报告.
- 对获得的血友病A.的诊断工作的审查.
- 在复杂的临床场景中解释凝血试验的讨论.
主要成果:
- 患者在服用抗凝药时经历了复发性血液瘤.
- 由于并发性血栓形成,获得血友病A的诊断被推迟.
- 这种延迟导致了长时间的住院和相关的疾病.
结论:
- 对AHA的快速治疗对于患有长期激活部分血栓形成时间 (aPTT) 的出血患者至关重要.
- 同时发生的血栓和出血情况使得AHA的诊断和治疗变得复杂.
- 提高医生意识和仔细的实验室解释对于及时的AHA诊断至关重要.
更多相关视频
13:08Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.0K
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.8K
相关概念视频
Disorders of Hemostasis
992
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
992
Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753
Introduction to Hemostasis
8.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.3K
Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
Extrinsic and Intrinsic Pathways of Hemostasis
8.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.3K
